Reducing Timelines for Vaccine Potency Testing
Shortening the vaccine development cycle by reducing the need for costly,
time-consuming manual analyses of vaccine potency is allowing pharma
and biotech companies to increase their throughput. Using this strategy,
automation can help to ensure that the most effective vaccines reach
the market more rapidly.
By Martin Smith at Synbiosis (March 2010)
Keywords: timelines, vaccine, potency, testing, cycle, market, rapidly, development, bacterial, viral, automated counting technology